Synapse - Works

Results (5608)

Export to EndNote / Excel

Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib

Journal Article

Molina, A. M.; Ginsberg, M. S.; Motzer, R. J.
Medical Oncology (2011)

Fulltext@MSK | Save

Circulating tumors cells as biomarkers: Progress toward biomarker qualification

Journal Article

Danila, D. C.; Pantel, K.; Fleisher, M.; Scher, H. I.
The Cancer Journal (2011)

Fulltext@MSK | Save

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial

Journal Article

Rini, B. I.; Escudier, B.; Tomczak, P.; Kaprin, A.; Szczylik, C.; Hutson, T. E.; Michaelson, M. D.; Gorbunova, V. A.; Gore, M. E.; Rusakov, I. G.; more...
Lancet (2011)

Fulltext@MSK | Save

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Journal Article

Poulikakos, P. I.; Persaud, Y.; Janakiraman, M.; Kong, X.; Ng, C.; Moriceau, G.; Shi, H.; Atefi, M.; Titz, B.; Gabay, M. T.; more...
Nature (2011)

Fulltext@MSK | Save

Fatigue improvement/reduction with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study

Meeting Abstract

Sternberg, C. N.; Scher, H. I.; Molina, A.; North, S.; Mainwaring, P.; Hao, Y.; Gagnon, D.; Kheoh, T.; Haqq, C. M.; de Bono, J.
European Journal of Cancer (2011)

Fulltext@MSK | Save

QT/QTc studies of abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC) - Analysis of 3 phase 1/2 studies

Meeting Abstract

Ryan, C. J.; Danila, D. C.; Tolcher, A.; Chi, K. N.; Tran, N.; Knoblauch, R.; Kheoh, T.; Haqq, C. M.; Scher, H. I.; Molina, A.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Assessment of progression-free survival as a surrogate endpoint for overall survival in patients with metastatic renal cell carcinoma

Meeting Abstract

Negrier, S.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Sandin, R.; Michaelson, M. D.; Figlin, R. A.; Motzer, R. J.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (LT-OS) with sunitinib in 1,059 patients, treated on clinical trials, with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
European Journal of Cancer (2011)

Fulltext@MSK | Save

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy

Journal Article

Kaag, M. G.; Milowsky, M. I.; Dalbagni, G.; Thompson, R. H.; Katz, D.; Reuter, V. E.; Herr, H. W.; Bajorin, D.; Bochner, B. H.
BJU International (2011)

Fulltext@MSK | Save

Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: A case series and review of the literature

Journal Article

Hyman, D. M.; Soff, G. A.; Kampel, L. J.
Oncology (2011)

Fulltext@MSK | Save